Journal Articles

Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling

Loes E.M. Kistemaker and Reinoud Gosens
Trends in Pharmacological Sciences March 2015, Vol. 36, No. 3
View article

Anti-inflammatory effects of targeted lung denervation in patients with COPD

Loes E.M. Kistemaker, Dirk-Jan Slebos, Herman Meurs, Huib A.M. Kerstjens and Reinoud Gosens.
European Respiratory Journal; In press DOI: 10.1183/13993003.00413-2015
View article

Antimuscarinic Bronchodilator Response Retained after Bronchoscopic Vagal Denervation inChronic Obstructive Pulmonary Disease Patients

Coenraad Frederik N. Koegelenberg, Johan Theron, Dirk-Jan Slebos, Karin Klooster, Martin Mayse, Reinoud Gosens
Respiration DOI: 10.1159/000447641
View article

Novel Endoscopic Approaches to Treating Chronic Obstructive Pulmonary Disease and Emphysema

D. Gompelmann, R. Eberhardt, F.J.F. Herth.
Semin Respir Crit Care Med 2015; 36(04): 609-615
DOI: 10.1055/s-0035-1555614
View article

Targeted lung denervation for moderate to severe COPD: a pilot study

Dirk-Jan Slebos, Karin Klooster, Coenraad F N Koegelenberg, Johan Theron, Dorothy Styen, Arschang
Valipour, Martin Mayse, Chris T Bolliger.
Thorax 2015; 70:411-419 doi: 10.1136/thoraxjnl-2014-206146
View article

Abstracts

2015

Additive effect of targeted lung denervation plus drug in patients with COPD

Coenraad Koegelenberg, Johan Theron, Dirk-Jan Slebos, Karin Klooster, Martin Mayse, Chris T Bolliger.
European Respiratory Journal. Volume 46 / Numero 3 / September 2015

Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure

Arschang Valipour, Christophe Pison, Romain Kessler, Gaetan Deslee.
European Respiratory Journal. Volume 46 / Numero 3 / September 2015

Two-year safety of targeted lung denervation in patients with moderate to severe COPD

Dirk-Jan Slebos, Karin Klooster, Coenraad Koegelenberg, Johan Theron, Martin Mayse, Chris T Bolliger.
European Respiratory Journal. Volume 46 / Numero 3 / September 2015

2014

Anti-inflammatory effects of targeted lung denervation in patients with COPD

Loes E.M. Kistemaker, Dirk-Jan Slebos, Herman Meurs, Huib A.M. Kerstjens, Reinoud Gosens.
European Respiratory Journal. Volume 44 / Supplement 58 / September 2014

Bilateral targeted lung denervation in patients with COPD in a single procedure

Arschang Valipour, Christophe Pison, Romain Kessler, Gaetan Deslee.
European Respiratory Journal. Volume 44 / Supplement 58 / September 2014

Efficacy of targeted lung denervation on patients with moderate to severe COPD

Dirk-Jan Slebos, Karin Klooster, Coenraad F.N. Koegelenberg, Johan Theron, Dorothy Steyn, Martin Mayse, Chris T. Bolliger.
European Respiratory Journal. Volume 44 / Supplement 58 / September 2014

Importance of surface cooling during targeted lung denervation for COPD

Martin Mayse, Philip Johnson, James Hummel.
European Respiratory Journal. Volume 44 / Supplement 58 / September 2014

Safety and feasibility of targeted lung denervation in patients with moderate to severe COPD

Dirk-Jan Slebos, Karin Klooster, Coenraad F.N. Koegelenberg, Johan Theron, Dorothy Steyn, Martin Mayse, Chris T. Bolliger.
European Respiratory Journal. Volume 44 / Supplement 58 / September 2014

Targeted lung denervation in the healthy sheep model – A potential treatment for COPD

Martin Mayse, Philip Johnson, John Streeter, Mark Deem, James Hummel.
European Respiratory Journal. Volume 44 / Supplement 58 / September 2014